SOCIAL BURDEN OF RHEUMATOID ARTHRITIS
https://doi.org/10.14412/1995-4484-2014-331-335
Abstract
The paper reviews data on the incidence of rheumatoid arthritis, disability, and the cost of treatment, including thera- py with biological agents.
About the Authors
I. Yu. Zinchuk
OOO «Pfizer», Moscow, Russia
Russian Federation
Russian Federation
V. N. Amirdzhanova
Nasonova Research Institute of Rheumatology, Moscow, Russia
Russian Federation
Russian Federation
References
1. World Health Organization, The Global Burden of Disease, 2004 Update. Accessed 13 March 2012. Available from: http://www.who.int/healthinfo/global_burden_disease/GBD_rep ort_2004update_full.pdf
2. Балабанова РМ, Эрдес ШФ. Динамика распространенности ревматических заболеваний, входящих в ХIII класс МКБ-10,
3. в популяции взрослого населения Российской Федерации за 2000–2010 гг. Научно-практическая ревматология. 2012;52(3):10–2. [Balabanova RM, Erdes ShF. Trends in the preva- lence of rheumatic diseases in ICD-10 in the adult population of the Russian Federation over 2000-2010. Nauchno-prakticheskaya revma- tologiya = Rheumatology Science and Practice. 2012;52(3):10–2. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1995-4484-2012-702.
4. Мясоедова СЕ, Лесняк ОМ, Меньшикова ЛВ. Распространенность ревматоидного артрита в России (по данным эпидемиологических исследований). Терапевтический архив. 2010;82(5):9–14. [Myasoedova SE, Lesnyak OM, Men'shikova LV. Prevalence of rheumatoid arthritis in Russia (according to epidemiological researches). Terapevticheskii arkhiv. 2010;82(5):9–14. (In Russ.)]
5. Verstappen SM, Bijlsma JW, Verkleij H, et al.; Utrecht Rheumatoid Arthritis Cohort Study Group. Overview of work dis- ability in rheumatoid Arthritis patients as observed in cross-sec- tional and longitudinal surveys. Arthritis Rheum. 2004 Jun. 15;51(3):488–97. DOI: http://dx.doi.org/10.1002/art.20419.
6. Da Silva E, Doran MF, Crowson CS, et al. Declining use of orthopedic surgery in patients with RA? Results of a long-term, population-based assessment). Arthritis Rheum. 2003;49(2):216–20. DOI: http://dx.doi.org/10.1002/art.10998.
7. Girard F, Guillemin F, Novella JL, et al. Health-care use by rheumatoid arthritis compared with non-arthritic subjects. Rheumatogoly (Oxford). 2002;41(2):167–75. DOI: http://dx.doi.org/10.1093/rheumatology/41.2.167.
8. Вакуленко ОЮ, Кричевская ОА, Горячев ДВ, Эрдес ШФ.
9. Взаимосвязь клинических характеристик ревматоидного артрита с трудоспособностью и производительностью труда. Научно-практическая ревматология. 2012;52(3):60–7. [Vakulenko OYu, Krichevskaya OA, Goryachev DV, Erdes ShF. Relationship of the clinical characteristics of rheumatoid arthritis to work capacity and efficiency. Nauchno-prakticheskaya revma- tologiya = Rheumatology Science and Practice. 2012;52(3):60–7. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1995-4484-2012-711.
10. Huscher D, Merkesdal S, Thiele K, et al. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis. 2006 Sep.;65(9):1175–83. DOI: http://dx.doi.org/10.1136/ard.2005.046367.
11. Kobelt G, Thoughts on health economics in rheumatoid arthritis). Ann Rheum Dis. 2007 Nov;6(3):iii35–9.
12. Bone and Joint Decade. European Action towards Better Musculoskeletal Health: A public health strategy to reduce the burden of musculoskeletal conditions. Lund: The Bone and Joint Decade, Department of Orthopedics, University Hospital; 2005
13. Young A, Dixey J, Kulinskaya E, et al. Which patients stop work- ing because of RA. Results of five years’ follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis. 2002;61(4):335–40. DOI: http://dx.doi.org/10.1136/ard.61.4.335.
14. Mau W, Bornmann M, Weber H, et al. Prediction of permanent work disability in a follow-up study of early rheumatoid arthritis: results of a tree structured analysis using RECPAM. Br J Rheumatol. 1996 Jul;35(7):652–9. DOI: http://dx.doi.org/10.1093/rheumatology/35.7.652.
15. Kobelt G, Eberhardt K, Jonsson L, Jö nsson B. Economic conse- quences of the progression of rheumatoid arthritis in Sweden. Arthritis Rheum. 1999;4(2):347–56. DOI: http://dx.doi.org/10.1002/1529-0131(199902)42:2%3C347::AID- ANR18%3E3.0.CO;2-P.
16. Fex E, Larsson BM, Nived K, Eberhardt K. Effect of rheumatoid arthritis on work status and social and leisure time activities in patients followed 8 years from onset. J Rheumatol. 1998 Jan; 25(1):44–50.
17. Borg G, Allander E, Berg E, et al. Auranofin treatment in early rheumatoid arthritis may postpone early retirement. Results from a 2-year double blind trial. J Rheumatol. 1991;18(17):1015–20.
18. Doeglas D, Krol B, Guillemin F, et al. The assessment of func- tional status in rheumatoid arthritis: a cross-cultural, longitudinal comparison of the Health Assessment Questionnaire and the Groningen Activity Restriction Scale. J Rheumatol. 1995 Oct; 22(10):1834–43.
19. Albers JM, Kuper HH, van Riel PL, et al. Socio-economic conse- quences of rheumatoid arthritis in the first years of the disease. Rheumatology (Oxford). 1999 May;38(5):423–30. DOI: http://dx.doi.org/10.1093/rheumatology/38.5.423.
20. Chorus AM, Miedema HS, Wevers CW, van der Linden S. Work factors and behavioural coping in relation to withdrawal from the labour force in patients with rheumatoid arthritis. Ann Rheum Dis. 2001 Nov;60(11):1025–32. DOI: http://dx.doi.org/10.1136/ard.60.11.1025.
21. Фоломеева OM, Насонов ЕЛ, Андрианова ИА и др. Ревматоидный артрит в ревматологической практике России: тяжесть заболевания в российской популяции больных. Одномоментное (поперечное) эпидемиологическое исследование (RAISER). Научно-практическая ревматология. 2010;(1):50–60. [Folomeeva OM, Nasonov EL, Andrianova IA, et al. Rheumatoid arthritis in rheumatological care of russia: the severity of the disease in a russian patient population: a cross-sectional epidemiological study (RAISER). Nauchno-prak- ticheskaya revmatologiya = Rheumatology Science and Practice. 2010;(1):50–60. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1995-4484-2010-1406.
22. Эрдес ШФ, Фоломеева ОМ. Проблема ревматических заболеваний в России. Русский медицинский журнал. 2004;12(20):1121–2. [Erdes ShF, Folomeeva OM. Problem of rheumatic diseases in Russia. Russkii meditsinskii zhurnal. 2004;12(20):1121–2. (In Russ.)]
23. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. DOI:10.1136/annrheumdis-2013-204573.
24. Ермакова ЮА. Влияние уровня активности на функциональный статус у пациентов с ранним ревматоидным артритом: результаты 5-летнего наблюдения
25. в рамках российской программы «РАДИКАЛ». Научно- практическая ревматология. Тезисы. 2013;51(Прил.):55–6. [Ermakova YuA. Influence of level of activity on the functional status at patients with early rheumatoid arthritis: results of 5 years' supervision within the Russian RADICAL program. Nauchno- prakticheskaya revmatologiya = Rheumatology Science and Practice. Theses. 2013;51(Suppl.):55–6. (In Russ.)]
26. Коршунов НИ, Речкина ЕВ. Ревматоидный артрит: болезнь и семья. Научно-практическая ревматология. Тезисы. 2013;51(Прил.)80–1. [Korshunov NI, Rechkina EV. Rheumatoid arthritis: illness and family. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. Theses. 2013;51(Suppl.):80–1. (In Russ.)]
27. Балабанова РМ, Амирджанова ВН, Насонов ЕЛ. Применение генно-инженерных биологических препаратов при ревматоидном артрите в Российской Федерации. Научно-практическая ревматология. 2012;50(6):10–4. [Balabanova RM, Amirdzhanova VN, Nasonov EL. Use of geneti- cally engineered biological drugs for rheumatoid arthritis in the Russian Federation. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2012;50(6):10–4. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1995-4484-2012-1286. Фармацевтический рынок России. Итоги 2012 года: Аналитический обзор DSM Group. Доступ по ссылке: http://www.dsm.ru/marketnews/1170_22.05.2013 [Farmatsevticheskii rynok Rossii. Itogi 2012 goda: Analiticheskii obzor DSM Group [Pharmaceutical market of Russia. Results of 2012: State-of-the-art review of DSM Group]. Available from: http://www.dsm.ru/marketnews/1170_22.05.2013]
28. IMS Health Россия. Аналитический обзор потребления лекарственных средств на территории Российской Федерации. Доступно по ссылке: http://www.imshealth.com/portal/site/imshealth [IMS Health Russia. Analiticheskii obzor potrebleniya lekarstvennykh sredstv na territorii Rossiiskoi Federatsii [The state-of-the-art review of con- sumption of medicines in the territory of the Russian Federation. Available from: http://www.imshealth.com/portal/site/imshealth] Cursor: аналитический обзор тендерных закупок лекарственных средств на территории России по итогам 2012 года. Доступ по ссылке: http://www.cursor- is.ru/ru/reports/Remedium.2012.pdf [Cursor: analiticheskii obzor tendernykh zakupok lekarstvennykh sredstv na territorii Rossii po itogam 2012 goda [Cursor: the state-of-the-art review of tender purchases of medicines in the territory of Russia following the results of 2012]. Available from: http://www.cursor- is.ru/ru/reports/Remedium.2012.pdf]
29. Приказ Минздрава России от 13.02.2013 No 66 «Об утверждении Стратегии лекарственного обеспечения населения Российской Федерации на период до 2025 года
30. и плана ее реализации». Доступно по ссылке: http://www.con- sultant.ru/law/hotdocs/24202.html [Prikaz Minzdrava Rossii ot 13.02.2013 No 66 «Ob utverzhdenii Strategii lekarstvennogo obe- specheniya naseleniya Rossiiskoi Federatsii na period do 2025 goda i plana ee realizatsii» [The order of Ministry of Health of Russia of 13.02.2013 No 66 «About the adoption of Strategy of provision of medicines of the population of the Russian Federation for the period till 2025 and the plan of its realization». Available from: http://www.consultant.ru/law/hotdocs/24202.html]
Review
For citations:
Zinchuk I.Yu., Amirdzhanova V.N. SOCIAL BURDEN OF RHEUMATOID ARTHRITIS. Rheumatology Science and Practice. 2014;52(3):331-335. (In Russ.) https://doi.org/10.14412/1995-4484-2014-331-335
Views:
1422
Email this article 